Zacks Investment Research on MSN
REGN soars 41% in six months: Is there more upside potential in 2026?
The going has been strong for Regeneron Pharmaceuticals REGN over the past six months. Shares of this biotech giant have ...
A UCLA-led research team has discovered a molecular switch that determines whether tiny blood vessels in premature infants' ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...
Active rash, interstitial lung disease and elevated neutrophil to lymphocyte ratio were independently associated with ...
News Medical on MSN
Inflammation and immune suppression fuel aggressive SCLC behavior and spread
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only five percent. Despite this poor prognosis, SCLC is initially highly responsive ...
As the Trump administration pushes to expand coal mining, advocates warn that loosening regulations could put miners' health at risk. Justin Hicks of the Appalachia Mid South Newsroom reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback